Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system

International Journal of Cancer

Volumn 80, Issue 3, 1999, Pages 425-430

  Kikuchi, Tetsuro ^a   Joki, Tatsuhiro ^a   Saitoh, Saburo ^a   Hata, Yuichi ^a   Abe, Toshiaki ^a   Kato, Naoki ^b   Kobayashi, Akihiro ^b   Miyazaki, Tomoaki ^b   Ohno, Tsuneya ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Basic Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 12; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GLIOMA; GLIOMA CELL; INTRAPERITONEAL DRUG ADMINISTRATION; IRRADIATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR CELL; TUMOR IMMUNITY; TUMOR LOCALIZATION;

ANIMALS; BRAIN NEOPLASMS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; FEMALE; GENETIC VECTORS; GLIOMA; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, NATURAL; MICE; NEOPLASM PROTEINS; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032911087     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990129)80:3<425::AID-IJC15>3.0.CO;2-7     Document Type: Article

References (21)

1. AOKI, T., TASHIRO, K., MIYATAKE, S., KINASHI, T., NAKANO, T., ODA, Y., KIKUCHI, H. and HONJO, T., Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc. nat. Acad. Sci. (Wash.). 89, 3850-3854 (1992).
2. BIANCHI, R., GROHMANN, U., BELLADONNA, M.L., SILLA, S., FALLARINO, F., AYROLDI, E., FIORETTI, M.C. and PUCCETTI, P., IL-12 is both required and sufficient for initiating T cell reactivity to a class 1-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells. J. Immunol. 157, 1589-1597 (1996).
3. BRANDES, A., SOESAN, M. and FIORENTINO, M., Medical treatment of high grade malignant gliomas in adults: an overview. Anticancer Res., 11, 1988-1992 (1991).
4. BRUNDA, M.J., Interleukin-12. J. Leukoc. Biol., 55, 280-288 (1994).
5. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F. and GATELY, M.K., Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. exp. Med., 178, 1223-1230 (1993).
6. COLOMBO, M.P., VAGLIANI, M., SPREAFICO, F., PARENZA, M., CHIODONI, C., MELANI, C. and STOPPACCIARO, A., Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res., 56, 2531-2534 (1996).
7. COUGHLIN, C.M., WYSOCKA, M., KURZAWA, H.L., LEE, W.M., TRINCHIERI, G. and ECK, S.L., B7-1 and interleukin 12 synergistically induce effective antitumor immunity. Cancer Res., 55, 4980-4987 (1995).
8. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D. and MULLIGAN, R.C., Vaccination with irradiated tumor cells engineered to secrete murine granulocytemacrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
9. FEARON, E.R., PARDOLL, D.M., ITAYA, T., GOLUMBEK, P., LEVITSKY, H.I., SIMONS, J.W., KARASUYAMA, H., VOGELSTEIN, B. and FROST, P., Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell, 60, 397-403 (1990).
10. GANSBACHER, B., BANNERH, R., DANIELS, B., ZIER, K., CRONIN, K. and GILBOA, E., Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res. 50, 7820-7825 (1990).
11. GATELY, M.K., WARRIER, R.R., HONASOGE, S., CARVAJAL, D.M., FAHERTY, D.A., CONNAUGHTON, S.E., ANDERSON, T.D., SARMIENTO, U., HUBBARD, B.R. and MURPHY, M., Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gammam in vitro. Int. Immunol., 6, 157-167 (1994).
12. + T cell-dependent tumor rejection. J. exp. Med., 174, 1291-1298 (1991).
13. MULLEN, C.A., COALE, M.M., LEVY, A.T., STETLER, S.W., LIOTTA, L.A., BRANDT, S. and BLAESE, R.M., Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity and decreased metastatic potential. Cancer Res., 52, 6020-6024 (1992).
14. NASTALA, C.L., EDINGTON, H.D., MCKINNEY, T.G., TAHARA, H., NALESNIK, M.A., BRUNDA, M.J., GATELY, M.K., WOLF, S.F., SCHREIBER, R.D., STORKUS, W.J. and LOTZE M.T., Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol., 153, 1697-1706 (1994).
15. RODOLFO, M., ZILOCCHI, C., MELANI, C., CAPPETTI, B., ARIOLI, I., PARMIANI, G. and COLOMBO, M.P., Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines. J. Immunol., 157, 5536-5542 (1996).
16. SAKAMOTO, K., HOSHINO, H., KIUCHI, Y., NAKANO, G. and NAGAMACHI, Y., Potential usefulness of a cultured glioma cell line induced by rous sarcoma virus in B10. A mouse as an immunotherapy model. Jap. J. exp. Med., 59, 173-180 (1989).
17. TEPPER, R.I., PATTENGALE, P.K. and LEDER, P., Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell, 57, 503-512 (1989).
18. TJUVAJEV, J., GANSBACHER, B., DESAI, R., BEATTIE, B., KAPLITT, M., MATEI, C., KOUTCHER, J., GILBOA, E. and BLASBERG, R., RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma. Cancer Res., 55, 1902-1910 (1995).
19. VAGLIANI, M., RODOLFO, M., CAVALLO, F., PARENZA, M., MELANI, C., PARMIANI, G., FORNI, G. and COLOMBO, M.P., Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells. Cancer Res., 56, 467-470 (1996).
20. WAKIMOTO, H., ABE, J., TSUNODA, R., AOYAGI, M., HIRAKAWA, K. and HAMADA, H., Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4. Cancer Res., 56, 1828-1833 (1996).
21. WIGGINTON, J.M., KOMSCHLIES, K.L., BACK, T.C.,. FRANCO, J.L., BRUNDA, M.J. and WILTROUT, R.H., Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J. nat. Cancer Inst., 88, 38-43 (1996).